Stock quote - Summary

Avacta Group
AVCT: 31.40 0.00 ( 0.00 %) delayed: 05:00AM
Bid price 30.00 High price 0.00
Ask price 32.00 Low price 0.00
Open price 0.00 Spread 0.00%
Prev close 31.00 Volume 0

Avacta Group - Share price charts

Historic - 6 months

Advanced Avacta Group charts >

Avacta Group - Share price information
Name Avacta Group Epic AVCT
Activities Avacta Group plc's (formerly Readybuy plc) principal focus is on its proprietary Affimer technology which is a novel engineered alternative to antibodies that has wide application in Life Sciences for diagnostics, therapeutics and general research and development. Antibodies dominate markets worth in excess of $50bn despite their shortcomings. Affimer technology has been designed to address many of these negative performance issues, principally; the time taken to generate new antibodies, the reliance on an animal's immune response, poor specificity in many cases, and batch to batch variability. Affimer technology is based on a small protein that can be quickly generated to bind with high specificity and affinity to a wide range of protein targets. Avacta has a pre-clinical biotech development programme with an in-house focus on immuno-oncology and bleeding disorders as well as partnered development programmes. Avacta is commercialising non-therapeutic Affimer reagents through licensing to developers of life sciences research tools and diagnostics. ISIN GB00BYYW9G87
Latest Share Price (p) 0.00 Net Gearing (%) -13.56
Market Capitalisation (pm) 35.79 Gross Gearing (%) 8.70
Shares in issue (m) 115.46 Debt Ratio 0.00
P/E Ratio -2.30 Debt-to-Equity Ratio 0.00
Total dividends per share (p) 0.00 Assets / Equity Ratio 1.10
Dividend Yield (%) 0.00 Price to book value 1.67
Dividend Cover 0.00 ROCE (%) -48.53
Earning per share (p) -13.49 EPS Growth (%) -44.90
52-week high / low (p) 68.75 / 21.20 DPS Growth (%) n/a
Avacta Group - Broker views
Date Broker Recommendation Price Old target price New target price Notes
12 Dec finnCap Corporate 120.00 - Reiterates
10 Dec finnCap Corporate 120.00 - Reiterates
10 Oct finnCap Corporate 120.00 - Reiterates
02 Oct finnCap Corporate 120.00 - Reiterates
31 Jul finnCap Corporate 120.00 - Reiterates

More Avacta Group broker views >

Avacta Group - Director deals
Date Director Type Volume / Price Trade value
13 Mar 2018 Prof Alastair Smith Buy 35,800 @ 41.92p £15,007.36
21 Aug 2017 Prof Alastair Smith Buy 33,225 @ 74.50p £24,752.63
05 Jul 2017 Michael Albin In Lieu of Fees/Salary 4,345 @ 86.30p £3,749.74
21 Oct 2016 Dr Mike Owen Buy 7,763 @ 90.00p £6,986.70
08 Jul 2016 Michael Albin Buy 3,393 @ 92.10p £3,124.95

More Avacta Group director deals >

Risk warning: Remember the price of shares can go down as well as up, and you are not guaranteed to get back the amount that you originally invested.
Click here to read the full warning.